QuietMIND Foundation (QMF) evaluates and promotes photobiomodulation, neurofeedback, and general health and wellness focused digital neurotherapeutic technologies. We personally study everything after conducting aggregated case series, open-label and randomized, double-blind, placebo-controlled clinical trials (i.e., what really works). We are continuously exploring new technologies and invite submissions from the med-tech, wearable sensing, digital therapeutics community to engage QMF to help to clinically evaluate your ideas and get the scientific validation they deserve.
Neuronic
Quietmind recommends the Neuradiant 1070nm transcranial photobiomodulation (TPBM) device from Neuronic Devices Ltd. QMF's founder and President, Marvin Berman became a co-founder of Neuronic to advance QMF's research agenda in the evolution of digital neurotherapeutic technology. Neuronic has rapidly become a global thought leader in the the field of wearable light therapy devices for enhancing brain health and wellness.
Neuronic is collaborating with leading neuroscience researchers and institutions worldwide to expand the efficacy of transcranial infrared light therapy technologies that may help to reverse memory loss and other symptoms associated with Alzheimer's and related neurodegenerative, neuropsychiatric and neurodevelopmental conditions. QMF's focus now is to assist Neuronic in delivering a closed-loop stimulation system providing, safe, reliable, customized, self-administered TPBM.
Narbis
Narbis provides an uniquely innovative Neurofeedback training approach that can help anyone develop their ability to enhance attention, concentration and focus.
Now offers a new tool, Illume, that combines photobiomodulation and tactile sensory stimulation to can enhance neurofeedback training effectiveness.
Experimental 1070nm Intranasal Stimulation Proof-of-Concept |
|
This unit has been developed specifically to deliver 200mw of 1070nm infrared light directly into the nose to support the immune system's response to COVID 19. There is a growing body of evidence supporting 1070nm transcranial near-infrared light photobiomodulation (tPBM) as a useful way to prevent COVID infection, reduce its virulence and mitigate enduring post-infection neurological injury, eg., long-COVID brain fog. Quietmind Foundation has developed and is conducting an open label case series investigation of an experimental intranasal PBM (iPBM) device designed to deliver 200mw of continuous 1070nm infrared photonic stimulation into one or both nostrils. |
DISCLAIMER
The content and information contained on this website are for educational and informational purposes only. The sources of referenced information could change or be updated in the future. Quietmind Foundation cannot guarantee the validity and accuracy of the sources, which may change, be modified, updated, or removed in the future, and thus, disclaims himself from any such changes, modifications, updates, and removals. The information provided in this website is not and must not be taken as an alternative to any advice by a doctor, physician, or medical professional. If you know or suspect you have a health problem, you should seek your physician’s advice. You should not use the information provided here for diagnosing an illness or other health-related problems. Further, you also should not discontinue professional medical or health care advice because of something they have read or seen on this website. Always consult with your doctor or professional health care specialist before using and relying on any data, information, or suggestion described on this website. Any reliance you make on any information presented here is at your sole discretion and risk. Quietmind Foundation and Marvin H Berman PhD hereby disclaim any liability for any medical outcome, directly or indirectly, in connection with the use of any information presented here.
The content and information contained on this website are for educational and informational purposes only. The sources of referenced information could change or be updated in the future. Quietmind Foundation cannot guarantee the validity and accuracy of the sources, which may change, be modified, updated, or removed in the future, and thus, disclaims himself from any such changes, modifications, updates, and removals. The information provided in this website is not and must not be taken as an alternative to any advice by a doctor, physician, or medical professional. If you know or suspect you have a health problem, you should seek your physician’s advice. You should not use the information provided here for diagnosing an illness or other health-related problems. Further, you also should not discontinue professional medical or health care advice because of something they have read or seen on this website. Always consult with your doctor or professional health care specialist before using and relying on any data, information, or suggestion described on this website. Any reliance you make on any information presented here is at your sole discretion and risk. Quietmind Foundation and Marvin H Berman PhD hereby disclaim any liability for any medical outcome, directly or indirectly, in connection with the use of any information presented here.
| nir_light_for_covid.pdf |
| jbio.202200391.r1_proof_hi.pdf |
| 1070nm PBM as Treatment for COVID 19 |
| nir_light_for_covid_2.pdf |
